SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 316 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,983 | -8.3% | 1,414 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $42,504 | -2.5% | 1,414 | +17.5% | 0.00% | -50.0% |
| Q1 2023 | $43,584 | +1.6% | 1,203 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $42,911 | +7.3% | 1,203 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $40,000 | +17.6% | 1,203 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $34,000 | -20.9% | 1,203 | -19.0% | 0.00% | 0.0% |
| Q4 2021 | $43,000 | +34.4% | 1,486 | +23.5% | 0.00% | 0.0% |
| Q3 2021 | $32,000 | -13.5% | 1,203 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $37,000 | +8.8% | 1,203 | -9.8% | 0.00% | 0.0% |
| Q1 2021 | $34,000 | +112.5% | 1,333 | +105.7% | 0.00% | +100.0% |
| Q4 2020 | $16,000 | +100.0% | 648 | +52.8% | 0.00% | 0.0% |
| Q3 2020 | $8,000 | -20.0% | 424 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $10,000 | -44.4% | 424 | -23.5% | 0.00% | 0.0% |
| Q2 2019 | $18,000 | -5.3% | 554 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $19,000 | +5.6% | 554 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $18,000 | -33.3% | 554 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $27,000 | -15.6% | 554 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $32,000 | +33.3% | 554 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $24,000 | +4.3% | 554 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $23,000 | +4.5% | 554 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $22,000 | 0.0% | 554 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $22,000 | +22.2% | 554 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $18,000 | +80.0% | 554 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $10,000 | 0.0% | 554 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $10,000 | 0.0% | 554 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $10,000 | +25.0% | 554 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $8,000 | +14.3% | 554 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $7,000 | -36.4% | 554 | -31.8% | 0.00% | -50.0% |
| Q3 2015 | $11,000 | -15.4% | 812 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $13,000 | – | 812 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |